Jul 30, 2020 / 12:00PM GMT
Operator
Good day, and welcome to Lantern Pharma's Second Quarter 2020 Earnings Conference Call. (Operator Instructions)
I would now like to introduce your host for the conference call, Director of Investor Relations at Lantern Pharma, Marek Ciszewski. Please go ahead.
Marek Ciszewski -
Thank you, Ashley, and thank you all for joining us for Lantern Pharma's Second Quarter 2020 Conference Call, our first as a publicly traded company. Our Q2 financial results and earnings press release was issued this morning and can be downloaded or viewed from the Investors section of our website. Also on this page, you will be able to find a slide deck with other financial and operational highlights that will be discussed on today's call.
On the call today are Panna Sharma, Lantern's President and CEO; and David Margrave, Lantern's CFO. Following the safe harbor statement, Panna will provide an overview of our business, after which David will share our quarterly financial results. Panna will then offer concluding comments, after which we will open this call for questions.
Q2 2020 Lantern Pharma Inc. Earnings Call Transcript
Jul 30, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers